<?xml version="1.0" encoding="UTF-8" ?>

<rss version="2.0"
  xmlns:ent="http://www.purl.org/NET/ENT/1.0/"
  xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
  <title>Multiple Sclerosis</title>
  <link>http://multiplesclerosis.blogharbor.com/blog</link>
  <description>A Informative Site about Multiple Sclerosis (MS).</description>
  <language>en-us</language>
  <lastBuildDate>Fri, 20 Nov 2009 02:06:09 -0600</lastBuildDate>
  <category domain="http://multiplesclerosis.blogharbor.com/blog">Main Page</category>
  <generator>Blogware</generator>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Email Me At:</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2008/1/16/3468561.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2008/1/16/3468561.html</guid>
    <pubDate>Sat, 09 May 2009 22:09:19 -0600</pubDate>
    <description>I encourage you to leave a comment for me.  You may email me at   MS.comments@AllAboutMS.ca



Please be advised that by emailing me you are giving me your permission 
</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog">Main Page</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Natalizumab associated with pro-inflammatory T cells</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/25/4265868.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/25/4265868.html</guid>
    <pubDate>Sat, 25 Jul 2009 00:00:00 -0600</pubDate>
    <description>Natalizumab is an antibody directed against integrin alpha4 that reduces disease activity in patients with multiple sclerosis (MS) by blocking migration of T and B cells into the  Central Nervouse System (CNS). The goal of this study was</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Research/DrugTrials">Drug Trials</category>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Therapies/TysabriNatalizumab/Research">Research</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Swine Flu Vaccination 2 of 2</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/24/4265876.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/24/4265876.html</guid>
    <pubDate>Fri, 24 Jul 2009 11:03:09 -0600</pubDate>
    <description>A flurry of innovative vaccine trials is in the offing as governments and regulatory agencies prepare for the probable launch of mass swine flu vaccination programs in the fall. 

The results of the trials could determine whether people</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information">Information</category>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Research">Research</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Swine flu Vaccines being Tested:</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/24/4264758.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/24/4264758.html</guid>
    <pubDate>Fri, 24 Jul 2009 00:00:00 -0600</pubDate>
    <description>Researchers at the University of Antwerp are currently comparing 4 potential vaccines for H1N1v, also known as swine flu or Mexican flu. 300 to 400 volunteers will be recruited for the tests. &quot;There is a good chance that a Mexican flu vaccine is available early November&quot;, expects vaccine expert Prof. Dr. Pierre van Damme, director of the</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information">Information</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Prediction of Relapses in Genes</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/23/4265109.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/23/4265109.html</guid>
    <pubDate>Thu, 23 Jul 2009 18:16:55 -0600</pubDate>
    <description>The ability to predict the spatial frequency of relapses in multiple sclerosis (MS) would enable physicians to decide when to intervene more aggressively and to plan clinical trials</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Diagnosing">Diagnosing</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Swine Flu - Vaccination 1 of 2</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/23/4264738.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/23/4264738.html</guid>
    <pubDate>Thu, 23 Jul 2009 11:23:26 -0600</pubDate>
    <description>A flurry of innovative vaccine trials is in the offing as governments and regulatory agencies prepare for the probable launch of mass swine flu vaccination programs in the</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information">Information</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Images of Lumbar Puncture (spinal tap)</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/21/4262492.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/21/4262492.html</guid>
    <pubDate>Tue, 21 Jul 2009 11:10:11 -0600</pubDate>
    <description>A lumbar puncture, or spinal tap, is a procedure to collect cerebrospinal fluid to check for the presence of disease or injury. A spinal needle is inserted, usually between the 3rd</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information">Information</category>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Diagnosing/SpinalTapLumbarPuncture">Spinal Tap (Lumbar Puncture)</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Tysabri – New Infection Linked – email from reader</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/20/4260447.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/20/4260447.html</guid>
    <pubDate>Mon, 20 Jul 2009 01:00:00 -0600</pubDate>
    <description>Thank you for your comment on my blog. I did not write that article. I reported it from Associated Press - Jun. 29, 2009. I put Associated Press - Jun. 29, 2009 on the bottom of the article to indicate that I did not write it. But</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information/EmailsfromReaders">Emails from Readers</category>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Therapies/TysabriNatalizumab">Tysabri (Natalizumab)</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Erroneous MS Diagnosis - email from reader</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/19/4260442.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/19/4260442.html</guid>
    <pubDate>Sun, 19 Jul 2009 15:03:51 -0600</pubDate>
    <description>Do you think it is possible that the MRI my neurologist gave me a few years ago would not have shown anything at the time b/c the condition wasn’t severe enough at the time? I’m just wondering if I should get tested again or if it is highly unlikely that it is related to ms? The double vision apparently was just &#39;one of those things that sometimes happens&#39; with my strong vision prescription. . and</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information/EmailsfromReaders">Emails from Readers</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Anxiety Support Group</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/19/4260430.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/19/4260430.html</guid>
    <pubDate>Sun, 19 Jul 2009 14:50:30 -0600</pubDate>
    <description>Generalized Anxiety Disorder – often called G.A.D (as in Gee Ah Dee not gad). This disorder causes chronic anxiety, even when there is not outward cause of it.
Obsessive-Compulsive Disorder – often</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information">Information</category>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/symptoms/Depression">Depression</category>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/symptoms/OddsandEnds">Odds and Ends</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Gamers Engage Memory, Attention, Processing Skills</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/18/4259283.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/18/4259283.html</guid>
    <pubDate>Sat, 18 Jul 2009 12:22:58 -0600</pubDate>
    <description>The MS Technology Collaborative has created a new way for people living with multiple sclerosis (MS) to exercise their brain power. The Collaborative, an alliance of Bayer HealthCare Pharmaceuticals, Microsoft, and the US National Multiple Sclerosis Society, announced the launch of</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information">Information</category>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/symptoms/CognitiveAbility">Cognitive Ability</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Berg Balance Scale</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/17/4258127.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/17/4258127.html</guid>
    <pubDate>Fri, 17 Jul 2009 10:05:03 -0600</pubDate>
    <description>(Used to measure balance of the older adult, and is now be used in some instances for people with MS)

The Berg Balance Scale (BBS) was developed to measure balance among older people with impairment in balance function by assessing the performance of functional tasks. It is a valid instrument used for evaluation of the effectiveness of interventions and for quantitative descriptions</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information">Information</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Prednisone &amp; Acetaminophen both for Flu Like Symptoms</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/16/4257207.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/16/4257207.html</guid>
    <pubDate>Thu, 16 Jul 2009 11:28:02 -0600</pubDate>
    <description>Prednisone or acetaminophen may significantly control flulike symptoms (FLSs) in patients with relapsing multiple sclerosis (MS) who are treated with interferon (IFN) beta-1a, according to a study presented here at the</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Therapies/Betaseron/Research">Research</category>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Therapies/Betaseron/Information">Information</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Second Chance For Dangerous T-cells</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/16/4256211.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/16/4256211.html</guid>
    <pubDate>Thu, 16 Jul 2009 00:00:00 -0600</pubDate>
    <description>The immune system&#39;s T-cells react to foreign protein fragments and therefore are crucial to combating viruses and bacteria. Errant cells that attack the body&#39;s own material are in most cases driven to cell death. Some of these autoreactive T-cells, however, undergo a kind of re-education to become &quot;regulatory T-cells&quot; that keep other</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information/TCells">T Cells</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>First Electronic Injection Device for MS</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/15/4256194.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/15/4256194.html</guid>
    <pubDate>Wed, 15 Jul 2009 10:28:08 -0600</pubDate>
    <description>Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the launch of the innovative individually adjustable electronic injection device RebiSmart(TM) for the self-administration of Rebif(R) (interferon beta-1a), the company&#39;s disease-modifying</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Therapies/Rebif/Research">Research</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Continuous Disease-Modifying Treatment = Better Outcomes in MS</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/15/4255240.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/15/4255240.html</guid>
    <pubDate>Wed, 15 Jul 2009 00:00:00 -0600</pubDate>
    <description>Patients with multiple sclerosis (MS) who adhere to their treatment with interferon (IFN) beta-1a without interruption have lower relapse and progression rates than patients who do not adhere to their medication as regularly</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Therapies/Rebif/Research">Research</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Smoking May Equal Rapid Progression of MS</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/14/4255223.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/14/4255223.html</guid>
    <pubDate>Tue, 14 Jul 2009 11:53:17 -0600</pubDate>
    <description>Patients with multiple sclerosis (MS) who smoke appear to experience a more rapid progression of their disease, according to a study published in the July issue of Archives of</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Research/Information">Information</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>reader email - drug trials</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/13/4253990.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/13/4253990.html</guid>
    <pubDate>Mon, 13 Jul 2009 11:05:20 -0600</pubDate>
    <description>I would like to be considered for any drug trials you may have. I am a 41 year old woman with RRMS, diagnosed</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information/EmailsfromReaders">Emails from Readers</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Tysabri – New Infection Linked</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/13/4252933.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/13/4252933.html</guid>
    <pubDate>Mon, 13 Jul 2009 00:00:00 -0600</pubDate>
    <description>company said late Friday it confirmed the presence of progressive multifocal leukoencephalopathy, or PML, on Tuesday. Biogen said the patient, who lives outside the U.S., had been using Tysabri for 30 months. Three of the ten</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Therapies/TysabriNatalizumab/Information">Information</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Kineta Acquires Novel Drug Candidates from Airmid</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/12/4252930.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/12/4252930.html</guid>
    <pubDate>Sun, 12 Jul 2009 11:38:18 -0600</pubDate>
    <description>Kineta, Inc. of Seattle and Airmid Incorporated of Redwood City, CA jointly announce an agreement in which a Kineta subsidiary has acquired exclusive commercial rights to a portfolio of novel therapeutic compounds from Airmid. The array of compounds holds extraordinary potential</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Research">Research</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>MS Glossary - Ac - Ce</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/11/4251751.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/11/4251751.html</guid>
    <pubDate>Sat, 11 Jul 2009 10:40:32 -0600</pubDate>
    <description>An immediate and short-lived, usually severe reaction in which the body responds to what is perceived to be a foreign substance with exaggerated symptoms, such as extreme itching, swelling, and often life-threatening respiratory</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information/MSGlossary">MS Glossary</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>phase III trial of Mylinax (oral cladribine)</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/10/4250982.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/10/4250982.html</guid>
    <pubDate>Fri, 10 Jul 2009 16:30:10 -0600</pubDate>
    <description>Over the two-year period of the study, 80% of the low dose regimen Cladribine arm and 79% of the high-dose regimen arm experienced no clinical relapse, compared with 61% of the</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Research/DrugTrials">Drug Trials</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Drug Trial - Female Stress Urinary Incontinence</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/10/4250975.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/10/4250975.html</guid>
    <pubDate>Fri, 10 Jul 2009 16:18:27 -0600</pubDate>
    <description>Over 11 million women in the United States suffer from stress urinary incontinence (SUI), the involuntary leakage of urine during routine physical activities such as laughing, coughing, exercising, or sneezing. SUI affects women</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Research/DrugTrials">Drug Trials</category>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/symptoms/BladderandBowel">Bladder and Bowel</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>U.S. Study Will Test Vitamin D, Fish Oil</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/6/4245753.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/6/4245753.html</guid>
    <pubDate>Mon, 06 Jul 2009 00:00:00 -0600</pubDate>
    <description>Two of the most popular and promising dietary supplements -- vitamin D and fish oil -- will be tested in a large, government-sponsored study to see whether either nutrient can lower a healthy person&#39;s risk of getting cancer</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Research/DrugTrials">Drug Trials</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Depression Improved By Telephone Therapy</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2006/1/22/1444264.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2006/1/22/1444264.html</guid>
    <pubDate>Sun, 05 Jul 2009 11:41:53 -0600</pubDate>
    <description>Patients with multiple sclerosis showed significant improvement in their depression during 16 weeks of telephone-administered psychotherapy treatment, according to an article </description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/symptoms/Depression">Depression</category>
    
    
    <ent:cloud ent:href="">
    
    <ent:topic ent:id="depression" ent:href="http://multiplesclerosis.blogharbor.com/blog/cmd=search_keyword/k=depression">depression</ent:topic>
    
    <ent:topic ent:id="psychotherapy" ent:href="http://multiplesclerosis.blogharbor.com/blog/cmd=search_keyword/k=psychotherapy">psychotherapy</ent:topic>
    
    <ent:topic ent:id="therapy" ent:href="http://multiplesclerosis.blogharbor.com/blog/cmd=search_keyword/k=therapy">therapy</ent:topic>
    
    </ent:cloud>
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Oral Laquinimod Phase III MS Clinical Trial</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/5/4245717.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/5/4245717.html</guid>
    <pubDate>Sun, 05 Jul 2009 11:02:51 -0600</pubDate>
    <description>Teva Pharmaceutical Industries Ltd. and Active Biotech today announced completion of patient enrollment for the second pivotal Phase III clinical trial, BRAVO, evaluating the novel, oral once-daily immunomodulating</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Research/DrugTrials">Drug Trials</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>New Theory for Why Repair of the Brain’s Wiring Fails</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/4/4243995.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/4/4243995.html</guid>
    <pubDate>Sat, 04 Jul 2009 00:00:00 -0600</pubDate>
    <description>Scientists have uncovered new evidence suggesting that damage to nerve cells in people with multiple sclerosis (MS) accumulates because the body’s natural mechanism for repairing the nerve coating</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Research/Other">Other</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Study - Spasticity</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/4/4243987.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/4/4243987.html</guid>
    <pubDate>Sat, 04 Jul 2009 00:00:00 -0600</pubDate>
    <description>This research study will evaluate a treatment for moderate to severe spasticity associated with MS. All patients must have been on baclofen for at least four weeks prior to first visit. This study requires</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Research/DrugTrials">Drug Trials</category>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/symptoms/Spasticity">Spasticity</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>MS Glossary - Re - Wh</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/4/4237895.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/4/4237895.html</guid>
    <pubDate>Sat, 04 Jul 2009 00:00:00 -0600</pubDate>
    <description>Reconstitution

The restoration to original form of a substance previously altered for preservation and storage

Reflex

An involuntary response of the nervous system to a stimulus, such as the stretch reflex, which is elicited by tapping a tendon with a reflex hammer, resulting in a contraction. Increased, diminished, or absent reflexes can</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Information/MSGlossary">MS Glossary</category>
    
    
    
    
  </item>
  
  <item>
    <dc:creator>All About MS</dc:creator>
    <title>Study - Restless Legs</title>
    <link>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/3/4243953.html</link>
    <guid>http://multiplesclerosis.blogharbor.com/blog/_archives/2009/7/3/4243953.html</guid>
    <pubDate>Fri, 03 Jul 2009 10:53:36 -0600</pubDate>
    <description>Discomfort or pain in your legs which worsens at night or when resting 
A strong urge to move your legs for relief 
Itching, pulling, creepy-crawly, tugging, or gnawing</description>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/Research/DrugTrials">Drug Trials</category>
    
    <category domain="http://multiplesclerosis.blogharbor.com/blog/symptoms/RestlessLegSyndrome">Restless Leg Syndrome</category>
    
    
    
    
  </item>
  
</channel>
</rss>
